Einloggen

Thematische Bibliographien / New medicines / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: New medicines.

Zeitschriftenartikel zum Thema „New medicines“

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 27. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "New medicines" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Parry, Parvaiz Ahmad, Aadil Hussain Tantray, and Aadil Mustafa Shabir Ahmad Ganie Mr Rajan Kothari. "Nutraceuticals: New Concept of Medicines." International Journal of Trend in Scientific Research and Development Volume-2, Issue-4 (2018): 153–58. http://dx.doi.org/10.31142/ijtsrd12970.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Godlee, F. "Good medicine rather than new medicines." BMJ 344, jun27 1 (2012): e4417-e4417. http://dx.doi.org/10.1136/bmj.e4417.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

S. Masmare, Suchita, and Vaishnavi V. Chitmuiwar. "New Advance Innovative Packaging of Medicines." International Journal of Science and Research (IJSR) 12, no. 12 (2023): 1350–52. http://dx.doi.org/10.21275/sr231214161633.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Mufadhol, Mufadhol, Mustafid Mustafid, Jie Ferry, and Noor Hidayah Yuni. "The new model for medicine distribution by combining of supply chain and expert system using rule-based reasoning method." International Journal of Artificial Intelligence (IJ-AI) 12, no. 1 (2023): 295–304. https://doi.org/10.11591/ijai.v12.i1.pp295-304.

Der volle Inhalt der Quelle

Annotation:

The medicine distribution supply chain is important, especially during the coronavirus disease 2019 (COVID-19) pandemic, because delays in medicine distribution can increase the risk for patients. So far, the distribution of medicines has been carried out exclusively and even some medicines are distributed on a limited basis because they require strict supervision from the Medicine Supervisory Agency in each department. However, the distribution of this medicine has a weakness if at one public health center there is a shortage of certain types of medicines, it cannot ask directly to other publ

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Hewson, Campbell, Chong Chi Shen, Clare Strachan, and Pauline Norris. "Personal medicines storage in New Zealand." Journal of Primary Health Care 5, no. 2 (2013): 146. http://dx.doi.org/10.1071/hc13146.

Der volle Inhalt der Quelle

Annotation:

INTRODUCTION: Poor storage of medicines can reduce their efficacy, yet little is known about how people store medicines in their homes and elsewhere, why these locations are chosen, and whether the conditions are suitable for medicines storage. AIM: To investigate where medicines are commonly stored in New Zealand households, why, and the typical conditions temperature and relative humidity in those places of storage. METHODS: Data from a large qualitative study on the meanings of medicines were analysed to explore where people store medicines in their households, and why. A data logger wa

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Fox, Andrew. "Biosimilar Medicines—New Challenges for a New Class of Medicine." Journal of Biopharmaceutical Statistics 20, no. 1 (2009): 3–9. http://dx.doi.org/10.1080/10543400903549892.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Nind, Fred, and Pam Mosedale. "New medicines guide." BSAVA Companion 2009, no. 3 (2009): 20–21. http://dx.doi.org/10.22233/20412495.0309.20.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Mills, Ann. "Discovering new medicines." Trends in Pharmacological Sciences 16, no. 3 (1995): 116. http://dx.doi.org/10.1016/s0165-6147(00)88994-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Dean, S. "New medicines regulations." Veterinary Record 157, no. 19 (2005): 599. http://dx.doi.org/10.1136/vr.157.19.599.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

DeFranco, Joanna F., and Jeffrey Voas. "Computing New Medicines." Computer 56, no. 2 (2023): 12–13. http://dx.doi.org/10.1109/mc.2022.3191933.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Tordoff, June, Michael Bagge, Farina Ali, et al. "Older people's perceptions of prescription medicine costs and related costs: a pilot study in New Zealand." Journal of Primary Health Care 6, no. 4 (2014): 295. http://dx.doi.org/10.1071/hc14295.

Der volle Inhalt der Quelle

Annotation:

INTRODUCTION: Older people tend to take more medicines and prescription medicine costs may influence medicine adherence. AIM: The aim of this pilot study was to identify older people's perceptions of prescription medicine costs and related costs in four major cities across New Zealand. METHODS: A questionnaire was administered to people aged 65 years and older visiting pharmacies in Auckland, Wellington, Christchurch, and Dunedin to identify their perceptions of costs relating to prescription medicines and related pharmacy and general practice services. Data were compared between cities and ex

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Taylor, Colman, and Michael Wonder. "Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand." Australian Health Review 39, no. 4 (2015): 455. http://dx.doi.org/10.1071/ah14122.

Der volle Inhalt der Quelle

Annotation:

Objective Spending on medicines under the Pharmaceutical Benefits Scheme (PBS) represents the ninth largest expense to the Federal Government. A recent report by the Commission of Audit to the Federal Government suggested spending on the PBS is unsustainable and a capped budget, similar to New Zealand’s PHARMAC model, may be required to contain costs. The objective of the present study was to compare listing outcomes between Australia and New Zealand, thereby exploring the opportunity cost of a capped budget for new medicines. Methods Listing outcomes in Australia and New Zealand were compared

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Carvalho, Ana Cecília Bezerra, João Paulo Silvério Perfeito, Leandro Viana Costa e Silva, Lívia Santos Ramalho, Robelma France de Oliveira Marques, and Dâmaris Silveira. "Regulation of herbal medicines in Brazil: advances and perspectives." Brazilian Journal of Pharmaceutical Sciences 47, no. 3 (2011): 467–73. http://dx.doi.org/10.1590/s1984-82502011000300004.

Der volle Inhalt der Quelle

Annotation:

The National Policy of Integrative and Complementary Practices (PNPIC) in the Brazilian Unified Health System (SUS), and The National Policy of Medicinal Plants and Herbal Medicines (PNPMF) were launched in 2006. Based on these, the Brazilian Health Surveillance Agency (ANVISA) re-edited rules related to herbal medicines such as the Guideline to herbal medicine registration (RDC 14/10), the Good Manufacture Practices Guideline (RDC 17/10) and the List of references to assess the safety and efficacy of herbal medicines (IN 05/10). The requisites to prove herbal medicine's safety and efficacy we

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Mufadhol, Mufadhol, Mustafid Mustafid, Ferry Jie, and Yuni Noor Hidayah. "The new model for medicine distribution by combining of supply chain and expert system using rule-based reasoning method." IAES International Journal of Artificial Intelligence (IJ-AI) 12, no. 1 (2023): 295. http://dx.doi.org/10.11591/ijai.v12.i1.pp295-304.

Der volle Inhalt der Quelle

Annotation:

The medicine distribution supply chain is important, especially during the COVID-19 pandemic, because delays in medicine distribution can increase the risk for patients. So far, the distribution of medicines has been carried out exclusively and even some medicines are distributed on a limited basis because they require strict supervision from the Medicine Supervisory Agency in each department. However, the distribution of this medicine has a weakness if at one public Health center there is a shortage of certain types of medicines, it cannot ask directly to other public Health center, thus allo

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Quinn, Gerry A., Aiya M. Banat, Alyaa M. Abdelhameed, and Ibrahim M. Banat. "Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery." Journal of Medical Microbiology 69, no. 8 (2020): 1040–48. http://dx.doi.org/10.1099/jmm.0.001232.

Der volle Inhalt der Quelle

Annotation:

Given the increased reporting of multi-resistant bacteria and the shortage of newly approved medicines, researchers have been looking towards extreme and unusual environments as a new source of antibiotics. Streptomyces currently provides many of the world’s clinical antibiotics, so it comes as no surprise that these bacteria have recently been isolated from traditional medicine. Given the wide array of traditional medicines, it is hoped that these discoveries can provide the much sought after core structure diversity that will be required of a new generation of antibiotics. This review discus

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Robinson, Martha K. "New Worlds, New Medicines: Indian Remedies and English Medicine in Early America." Early American Studies: An Interdisciplinary Journal 3, no. 1 (2005): 94–110. http://dx.doi.org/10.1353/eam.2007.0022.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Creighton, Dot. "New Veterinary Medicines Act." Veterinary Nursing Journal 20, no. 11 (2005): 10–11. http://dx.doi.org/10.1080/17415349.2005.11013414.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Hardy, B. "New rules on medicines." Veterinary Record 136, no. 4 (1995): 107. http://dx.doi.org/10.1136/vr.136.4.107-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Wray, J. "New rules on medicines." Veterinary Record 136, no. 5 (1995): 130–31. http://dx.doi.org/10.1136/vr.136.5.130.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Dean, S. "New rules on medicines." Veterinary Record 136, no. 5 (1995): 130. http://dx.doi.org/10.1136/vr.136.5.130-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Young, A. "New rules on medicines." Veterinary Record 136, no. 6 (1995): 156. http://dx.doi.org/10.1136/vr.136.6.156-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Barbour-Hill, E. "New rules on medicines." Veterinary Record 136, no. 7 (1995): 178–79. http://dx.doi.org/10.1136/vr.136.7.178.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Michell, B. "New rules on medicines." Veterinary Record 136, no. 7 (1995): 179. http://dx.doi.org/10.1136/vr.136.7.179-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Gillian, S., D. Corrin, C. May, et al. "New rules on medicines." Veterinary Record 136, no. 8 (1995): 203. http://dx.doi.org/10.1136/vr.136.8.203-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Cook, R. "New rules on medicines." Veterinary Record 136, no. 9 (1995): 227–28. http://dx.doi.org/10.1136/vr.136.9.227.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Scott, W. "New rules on medicines." Veterinary Record 136, no. 9 (1995): 227. http://dx.doi.org/10.1136/vr.136.9.227-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Pepper, D. "New rules on medicines." Veterinary Record 136, no. 9 (1995): 227. http://dx.doi.org/10.1136/vr.136.9.227-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Jacklin, M. "New rules on medicines." Veterinary Record 136, no. 9 (1995): 227. http://dx.doi.org/10.1136/vr.136.9.227-c.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Hill, L. "New rules on medicines." Veterinary Record 136, no. 9 (1995): 227. http://dx.doi.org/10.1136/vr.136.9.227-d.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

GOLDSTEIN, A. L., and E. GARACI. "Preface: The "New Medicines"." Annals of the New York Academy of Sciences 1112, no. 1 (2007): xi—xii. http://dx.doi.org/10.1196/annals.1415.053.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Cuthbert, M. F., and E. Griffiths. "Medicines from New Biotechnologies." Journal of the Royal Society of Medicine 81, no. 3 (1988): 126–28. http://dx.doi.org/10.1177/014107688808100302.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Cohen, Jack S., and Michael E. Hogan. "The New Genetic Medicines." Scientific American 271, no. 6 (1994): 76–82. http://dx.doi.org/10.1038/scientificamerican1294-76.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

White, M. "New rules on medicines." Veterinary Record 136, no. 1 (1995): 23. http://dx.doi.org/10.1136/vr.136.1.23-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Done, J. "New rules on medicines." Veterinary Record 136, no. 10 (1995): 251. http://dx.doi.org/10.1136/vr.136.10.251-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Barbour-Hill, E. "New rules on medicines." Veterinary Record 136, no. 10 (1995): 251. http://dx.doi.org/10.1136/vr.136.10.251-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Aitken, M. "New rules on medicines." Veterinary Record 136, no. 10 (1995): 251. http://dx.doi.org/10.1136/vr.136.10.251-c.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Michell, B. "New rules on medicines." Veterinary Record 136, no. 11 (1995): 274. http://dx.doi.org/10.1136/vr.136.11.274-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Dale, C. "New rules on medicines." Veterinary Record 136, no. 12 (1995): 303. http://dx.doi.org/10.1136/vr.136.12.303-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Brander, G. "New rules on medicines." Veterinary Record 136, no. 12 (1995): 303. http://dx.doi.org/10.1136/vr.136.12.303-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Taylor, P., A. Waterman, R. Jones, K. Clarke, J. Reid, and R. Clutton. "New rules on medicines." Veterinary Record 136, no. 13 (1995): 334. http://dx.doi.org/10.1136/vr.136.13.334.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Eddy, R. "New rules on medicines." Veterinary Record 136, no. 14 (1995): 371–72. http://dx.doi.org/10.1136/vr.136.14.371.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Stuart, N. "New rules on medicines." Veterinary Record 136, no. 16 (1995): 423. http://dx.doi.org/10.1136/vr.136.16.423-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Cumming, C. "New rules on medicines." Veterinary Record 136, no. 16 (1995): 423. http://dx.doi.org/10.1136/vr.136.16.423-c.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

DeVile, C. "New rules on medicines." Veterinary Record 136, no. 2 (1995): 51. http://dx.doi.org/10.1136/vr.136.2.51-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Cormie, J. "New rules on medicines." Veterinary Record 136, no. 2 (1995): 51. http://dx.doi.org/10.1136/vr.136.2.51-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Smith, Adam. "New Safe Medicines Faster." Trends in Pharmacological Sciences 22, no. 2 (2001): 62. http://dx.doi.org/10.1016/s0165-6147(00)01651-5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Mordmüller, Benjamin. "New medicines for malaria." Wiener klinische Wochenschrift 122, S1 (2010): 19–22. http://dx.doi.org/10.1007/s00508-010-1330-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Finkle, Bryan. "New medicines from industry." Journal of Chemical Technology & Biotechnology 43, no. 4 (2007): 313–27. http://dx.doi.org/10.1002/jctb.280430411.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Esteve Salà, Emili. "The availability of medicines in Spain." Anales de la Real Academia Nacional de Farmacia 88, no. 88(05) (2022): 667–74. http://dx.doi.org/10.53519/analesranf.2022.88.05.28.

Der volle Inhalt der Quelle

Annotation:

In the European Union (EU) procedures for the authorization of medicinal products are applied to incorporate new medicinal products and their successive amendments under the same conditions in all Member States. However, the effective marketing of medicinal products differs, and the intended harmonization based on a single authorization valid for the whole EU is fragmented by the subsequent intervention of the Member States responsible for price and reimbursement. The difference in the availability of medicines affects patients when the product is not effectively marketed. Spain was in an inte

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Luzhanin, V. G., V. A. Kurkin, and I. V. Gravel. "Quality of Herbal Medicines: New Aspects and Solutions." Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation 13, no. 2 (2023): 128–33. http://dx.doi.org/10.30895/1991-2919-2023-13-2-128-133.

Der volle Inhalt der Quelle

Annotation:

Herbal drugs and herbal medicinal products remain of interest to Russian researchers both in terms of the development, efficacy, and safety of medicines, and in terms of the research methodology applicable to these medicine, as well as the use of new analytical methods expanding the boundaries of contemporary science and medicine. In this interview, Vladimir G. Luzhanin (Candidate of Sciences, Associate Professor, Rector of the Perm State Pharmaceutical Academy), Vladimir A. Kurkin (Doctor of Pharmaceutical Sciences, Full Professor, Chairman of the Department of Pharmacognosy with Botany and t

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!